France· FR:64630264
APOKINON 30 mg/3 ml (1 %), solution injectable en stylo pré-rempli
A medicinal product containing chlorhydrate d'apomorphine, registered in France by AGUETTANT, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'APOMORPHINE
- Manufacturer
- AGUETTANT
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009338705771 cartouche(s) en verre de 3 ml avec stylo injecteurEUR 25.01
- cip1334009338706385 cartouche(s) en verre de 3 ml avec stylo injecteurEUR 119.42
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate d'apomorphine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAPO-go Ampullen 10 mg/ml oplossing voor injectie of infusieStada Arzneimittel AG
- IrelandAPO-go AMPOULES 10 mg/ml Solution for Injection or Infusion *Abbreviated to APO-go in the textStada Arzneimittel AG
- CzechiaBRITAJECTSTADA Arzneimittel AG, Bad Vilbel
- FinlandApogo PenSTADA Arzneimittel AG
- United KingdomAPO-go 20mg/2ml solution for injection ampoulesBritannia Pharmaceuticals Ltd
- SpainAPO-GO 10 mg/ml SOLUCIÓN INYECTABLE O PARA PERFUSIÓN EN AMPOLLASStada Arzneimittel Ag
- SwedenAPO-go 10 mg/ml Injektions-/infusionsvätska, lösningSTADA Arzneimittel AG
- SwitzerlandAPO-go
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Apo-Go, Apo-Go Ampullen
- Belgium · Apo-Go ®-Cartridge, Apo-Go-Pen
- Bulgaria · Dacepton, Апо-Гo Пнс
- Cyprus · Apo-Go Pfs, Apo-Go Συσκευή Τύπου Πένασ
- Czechia · Britaject, Britaject Pen
- Germany · Apo-Go, Apo-Go Ampullen
- Denmark · Apo-Go Pen, Apo-Go Pod
- Estonia · Apo-Go, Dacepton
- Spain · Apo-Go, Apo-Go Pen
- Finland · Apogo Pen, Dacepton
- United Kingdom (Northern Ireland) · Apo-Go Ampoules, Apo-Go Pen
- Greece · Apo-Go Pfs, Apo-Go Pod
- Croatia · Dacepton
- Hungary · Dacepton
- Ireland · Apo-Go Ampoules, Apo-Go Pen
- Italy · Apofin, Dacepton
- Lithuania · Britaject, Dacepton
- Luxembourg · Apo-Go Ampoules, Apo-Go Pen
- Latvia · Apo-Go, Apo-Go Pen
- Malta · Apo-Go Pen, Apo-Go Pfs
- Netherlands · Apo-Go, Apo-Go Ampullen
- Norway · Apomorfin Pharmswed, Britaject
- Poland · Dacepton
- Portugal · Apo-Go, Apo-Go Pen
- Romania · Apo-Go
- Sweden · Apo-Go, Apo-Go För Pod
- Slovenia · Apo-Go, Dacepton
- Slovakia · Dacepton
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6e928ef9-1268-498f-bc74-07b89cf3dce8 GET /v1/drugs/6e928ef9-1268-498f-bc74-07b89cf3dce8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64630264",
"date_amm": "1995-03-16",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE D'APOMORPHINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate d'apomorphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.